Oncology
Elad Sharon, M.D.
Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha
Elad Sharon, M.D., is a medical oncology specialist at Dana-Farber Cancer Institute and Harvard Medical School, where he serves as Director of the Immunotherapy Toxicity Program. His clinical expertise encompasses cancer immunotherapy, CAR-T cell therapy, bladder and urothelial cancer treatments, and supportive care including oral health management in cancer patients. With over 600 peer-reviewed publications, Dr. Sharon is a recognized leader in advancing cancer diagnosis and treatment through i
23+
Years in Practice
Credentials
Board Certifications
- Internal Medicine
- Medical Oncology
Education & Training
- Baylor College of Medicine (MD)
- Emory University School of Medicine (Residency)
- National Institutes of Health (Fellowship)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
Experience
23+ years in practice